BWXT vs CEG: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CEG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BWXT and CEG share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BWXT and CEG exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

BWX Technologies is a US supplier of nuclear components and fuel, serving government and commercial customers. Its largest business is providing the nuclear reactors and reactor components that power the US Navy's submarines and aircraft carriers, a role in which it is effectively the sole-source manufacturer. BWXT also produces nuclear fuel and reactor parts, manages and operates national laboratory and government nuclear sites, handles nuclear materials, and increasingly pursues commercial opportunities in medical radioisotopes, advanced and small modular reactors, and nuclear components for the broader power industry. The company makes money largely through long-cycle government defense contracts that provide multi-year revenue visibility, supplemented by growing commercial and medical lines. Headquartered in Lynchburg, Virginia, BWXT operates specialized, highly regulated manufacturing facilities that are difficult to replicate, giving it a deep moat in naval nuclear propulsion.

Full BWXT guide

Constellation Energy (CEG) is the largest producer of carbon-free electricity in the United States, operating the country's biggest fleet of nuclear power plants alongside hydro, wind, and solar assets. Spun off from Exelon in 2022, it generates and sells power and provides energy services to commercial, industrial, government, and residential customers. Constellation's nuclear fleet produces large, steady volumes of around-the-clock, low-carbon electricity, which has become increasingly valuable as datacenters, electrification, and AI computing drive up demand for reliable clean power. The company has pursued long-term power-supply agreements with large energy buyers, including technology companies seeking carbon-free electricity for datacenters, and on January 7, 2026 closed its acquisition of Calpine, a major natural-gas and geothermal generator, which broadened its generation mix and roughly lifted trailing revenue to about $31 billion. The Justice Department required divestitures as a condition: the 606 MW Brazos Valley plant in Texas was sold to LS Power for about $860 million (closed October 14, 2026), and about 4.4 GW of mostly gas assets in Delaware and Pennsylvania are being sold to LS Power with closing expected by the end of 2026. Headquartered in Baltimore, Maryland, Constellation benefits from federal clean-energy incentives, including production tax-credit support for existing nuclear plants.

Full CEG guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BWXT drivers: Naval nuclear propulsion backbone; Commercial nuclear and SMR tailwinds.
• CEG drivers: Datacenter and AI power demand; Nuclear fleet value and clean-energy support.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: BWXT is heavily dependent on US government defense spending; budget delays, continuing resolutions, or shifts in shipbuilding priorities could pressure revenue and backlog timing. For CEG, constellation has merchant exposure, so its results depend partly on wholesale power and commodity prices, which can be volatile.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BWXT if you believe its drivers more; CEG if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BWXT and CEG guides.

BWXT. As of October 16, 2026, BWXT trades near ~$137.69, about 36x trailing earnings and 26x the ~$5.23 analysts expect for 2027, still a premium to most defense industrials even after a roughly 24% year-to-date decline. The compression came while guidance rose, so the market has been re-pricing the nuclear-renaissance optionality rather than reacting to weaker results. Sixteen analysts carry a Buy consensus with a mean target near ~$209.

CEG. Constellation still trades at a higher multiple than most regulated utilities, about 27 times trailing and 21 times forward earnings, because investors price in growth from AI and datacenter power demand and the premium value of carbon-free baseload generation. The multiple has compressed in 2026 even as guidance rose and big tech contracts were signed, which leaves the stock well below the analyst mean target near $338. All figures are approximate as of October 16, 2026 and move with power prices and the share price.

Headline figures (approximate, October 2026): BWXT shows revenue (ttm) ~$3.51B (+18% latest quarter), 2026 guidance ~$3.80B revenue; adj. EPS $4.70-4.80, margins (operating / net) ~10.4% / ~10.1%, net income (ttm) ~$355M; CEG shows revenue (ttm) ~$31.3 billion (Q2 2026 up ~23% YoY with Calpine), q2 2026 adjusted operating eps $2.55 vs ~$2.28 estimate (GAAP $1.42), 2026 adjusted operating eps guidance $11.50-12.50 (raised), net income (ttm) ~$3.5 billion.

BWXT and CEG are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BWXT and CEG exposure against your real portfolio. It is not an investment adviser.